z-logo
open-access-imgOpen Access
Bezpieczeństwo i skuteczność protokołu wenetoklaks–rytuksymab u chorej na przewlekłą białaczkę limfocytową leczonej uprzednio inhibitorem BTK
Author(s) -
Joanna DrozdSokołowska,
Grzegorz W. Basak
Publication year - 2020
Publication title -
hematologia
Language(s) - Bosnian
Resource type - Journals
eISSN - 2081-3287
pISSN - 2081-0768
DOI - 10.5603/hem.2020.0022
Subject(s) - venetoclax , medicine , rituximab , chemoimmunotherapy , neutropenia , ibrutinib , chronic lymphocytic leukemia , fludarabine , gastroenterology , oncology , immunology , leukemia , lymphoma , chemotherapy , cyclophosphamide

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here